Phenotypic Characteristics of Superlean Individuals Including Gut Microbiome

NCT ID: NCT05804929

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

104 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to build on our previous work to further characterise the phenotype of superlean individuals (BMI \< 18.5) when compared to normal BMI people (BMI 21.5 to 25). This will include characterising the body composition, food intake behaviour, circulating hormone levels, genetics and characteristics of the gut microbiota. The investigators expect to recruit up to 200 healthy superlean and control volunteers respectively,

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The focus of this work is to characterise the phenotype and genotype of individuals who have low BMI ( \< 18.5) but are otherwise healthy and do not have eating disorders. The investigators term this group 'superlean' individuals. The study is observational and the investigators aim to establish a healthy superlean cohort,and use the combined metagenomic and metabolomic multi-omics analysis techniques, combined with imaging and physiological measurements, to focus on the correlation between gut microbiota characteristics and metabolism in superlean population. The investigators expect to recruit up to 200 healthy superlean and control volunteers (BMI 21.5 to 25) respectively, to explore the microbiota characteristics and differences between control and healthy superlean populations by measuring the basic physical indicators and metabolic parameters. This will include analyzing the postprandial hormonal changes, appetite differences, and changes in the gut microbiome and serum metabolome in the two groups of volunteers, establishing the relationship between the gut microbiota and the metabolite and metabolic phenotypes of the body, and exploring the gut microbiota.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thinness Health Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

21.5≤BMI\<25, age between 25-40 years old, 200subjects.

Observation without intervention

Intervention Type OTHER

Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.

Superlean

BMI≤18.5, age between 25-40 years old, 200 subjects.

Observation without intervention

Intervention Type OTHER

Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation without intervention

Observation of food intake, body composition, microbiota, genetics, metabolic rate, metabolomics.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Control group (21.5≤ BMI\<25), Superlean group (BMI≤18.5)
* Age between 25-40 years old

Exclusion Criteria

* Having metabolic diseases or eating disorders
* Recent weight loss due to various disease causes
* Being treated for weight loss
* Having an infectious disease
* Pregnant and lactating women
* People with blood sickness, pathological hypo- or hypertension
* People suffering from claustrophobia
* No metal implants in the body
* Use of antibiotics, probiotics, oral laxatives, etc. within 8 weeks
Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John R. Speakman

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shenzhen Institute of Advanced Technology,

Shenzhen, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SIAT-IRB-221115-H0628

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

China Health Big Data
NCT03699228 RECRUITING